The use of genetic tests aimed at detecting mutations in the BRCA1 and BRCA2 genes in women with breast cancer is declining in favor of tests that can detect multiple cancer-associated mutations, according to researchers at the Stanford University School of Medicine and five other U.S. medical centers. Some researchers had wondered whether multigene… Continue reading Multigene Testing Replacing BRCA Tests for Breast Cancer Risk